Breaking News Instant updates and real-time market news.

2019-02-14 06:06:57 YETI Yeti $18.66 0.25 (1.36%) 06:06 02/14/19 02/14 06:06 02/14/19 06:06	Yeti sees FY19 adjusted EPS 99c-$1.04, consensus 96c Sees FY19 Net sales increasing between 11.5%-13% compared to fiscal 2018 with growth across both channels led by the DTC channel, consensus $867.76M.	14 Feb
YETI Yeti $18.66 0.25 (1.36%) 01/14/19 BARD 01/14/19 NO CHANGE Target $23 BARD Outperform Yeti bullish thesis reinforced by Q4 update, says Baird Baird analyst Peter Benedict noted Yeti provided a positive Q4 update which he said reinforces his bullish thesis. The analyst believes the company is on track to be a $1B brand within the next 2-3 years as rising brand awareness, ongoing product innovation, and a broadening geographic footprint will support its growth. Benedict reiterated his Outperform rating and $23 price target on Yeti shares. 01/14/19 JEFF 01/14/19 NO CHANGE Target $35 JEFF Buy Yeti target raised to $35 after 'strong' Q4 at Jefferies Yeti's preliminary Q4 results were strong, as the brand continues to gain credibility in non-core categories and mix shifts favorably to direct-to-consumer, Jefferies analyst Randal Konik tells investors in a post-earnings research note. The analyst sees "significant opportunity" for Yeti to expand its total addressable market and boosted his price target for the shares to $35 from $34. He keeps a Buy rating on the name. 01/15/19 PIPR 01/15/19 NO CHANGE Target $25 PIPR Overweight Piper ups Yeti target to $25, calls valuation 'very reasonable' Piper Jaffray analyst Peter Keith views Yeti's preliminary Q4 results as strong and indicative of potential sales and margin upside the company can drive going forward. Importantly, high margin direct-to-consumer sales drove most of the upside, as Yeti appears to be leveraging its recently launched national advertising, Keith tells investors in a research note after meeting with management. He continues to view the stock's valuation as "very reasonable" given the company's "strong fundamentals." The analyst raised his price target for Yeti to $25 from $24 and reiterates an Overweight rating on the name. 01/15/19 BARD 01/15/19 NO CHANGE Target $23 BARD Outperform Fresh Pick designation removed from Yeti, Outperform rating reiterated at Baird Baird analyst Peter Benedict closed out his Fresh Pick designation on Yeti as his associated tactical catalysts have unfolded. The analyst said he continues to see significant upside opportunity for the shares longer-term as brand awareness grows and ongoing product innovation expands. Benedict reiterated his Outperform rating and $23 price target on Yeti shares.

2019-02-14 06:06:57

YETI

Yeti

$18.66: 0.25 (1.36%)

06:06

02/14/19

02/14

06:06

02/14/19

06:06

Yeti sees FY19 adjusted EPS 99c-$1.04, consensus 96c

Sees FY19 Net sales increasing between 11.5%-13% compared to fiscal 2018 with growth across both channels led by the DTC channel, consensus $867.76M.

14
Feb

YETI Yeti

$18.66: 0.25 (1.36%)

01/14/19: BARD

01/14/19: JEFF

01/15/19: PIPR

01/15/19: BARD

TODAY'S FREE FLY STORIES

ARAY Accuray $5.26 0.09 (1.74%) 07:38 02/22/19 02/22 07:38 02/22/19 07:38 Hot Stocks	Accuray reports results from SBRT trial » Accuray announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
C Citi $64.31 -0.35 (-0.54%) 07:36 02/22/19 02/22 07:36 02/22/19 07:36 Upgrade	Citi rating change » Jefferies sees positive… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb 15 Apr 28 May 13 Jul
BCLI BrainStorm $3.88 0.01 (0.26%) 07:35 02/22/19 02/22 07:35 02/22/19 07:35 Hot Stocks	BrainStorm announces first U.S.clinical site for Phase 2 MS study » BrainStorm announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WPC W.P. Carey $74.39 0.25 (0.34%) 07:35 02/22/19 02/22 07:35 02/22/19 07:35 Earnings	Breaking Earnings news story on W.P. Carey » W.P. Carey sees FY19 AFFO… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
KEYS Keysight Technologies $81.74 0.67 (0.83%) 07:35 02/22/19 02/22 07:35 02/22/19 07:35 Recommendations	Keysight Technologies analyst commentary » Keysight Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb

WFT Weatherford $0.78 -0.0436 (-5.32%) , KR Kroger $28.55 -0.2 (-0.70%) … 07:35 02/22/19 02/22 07:35 02/22/19 07:35 Options	Unusual call flow in option market yesterday » Notable call activity was… WFT Weatherford $0.78 -0.0436 (-5.32%) KR Kroger $28.55 -0.2 (-0.70%) I Intelsat $24.59 0.5 (2.08%) BSX Boston Scientific $40.12 -0.01 (-0.02%) OAS Oasis Petroleum $6.07 -0.28 (-4.41%) MNST Monster Beverage $58.87 0.16 (0.27%) LKQ LKQ Corp. $27.33 0.36 (1.33%) DK Delek US $36.18 -0.8953 (-2.41%) AGI Alamos Gold $4.82 -0.055 (-1.13%) APEI American Public Education $32.93 0.88 (2.75%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 27 Feb 27 Feb 27 Feb 03 Mar 04 Mar 06 Mar 11 Mar 12 Mar 28 Mar 18 May 22 May 28 May
07:35 02/22/19 02/22 07:35 02/22/19 07:35 General news	Treasury Market Outlook: yields are lower in the U.S. and Europe » Treasury Market Outlook:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
WPC W.P. Carey $74.39 0.25 (0.34%) 07:34 02/22/19 02/22 07:34 02/22/19 07:34 Earnings	W.P. Carey reports Q4 AFFO $1.33, consensus $1.33 » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
BXG Bluegreen Vacations $13.92 -0.12 (-0.85%) 07:34 02/22/19 02/22 07:34 02/22/19 07:34 Earnings	Bluegreen Vacations reports Q4 EPS 27c, consensus 24c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
TEF Telefonica $8.85 0.12 (1.37%) 07:33 02/22/19 02/22 07:33 02/22/19 07:33 Hot Stocks	EU says Telefonica breached commitment in E-Plus acquisition » The European Commission… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb

CONE CyrusOne $52.44 -4.75 (-8.31%) 07:33 02/22/19 02/22 07:33 02/22/19 07:33 Recommendations	CyrusOne analyst commentary » CyrusOne price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Mar 18 Jun
BIIB Biogen $320.99 -14.02 (-4.18%) 07:33 02/22/19 02/22 07:33 02/22/19 07:33 Downgrade	Biogen rating change » Biogen downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 28 May
INSM Insmed $25.57 -0.42 (-1.62%) 07:33 02/22/19 02/22 07:33 02/22/19 07:33 Hot Stocks	Insmed sees FY19 ARIKAYCE revenues $80M-$90M » Insmed expects cash-based… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
OPNT Opiant Pharmaceuticals $14.65 -0.25 (-1.68%) 07:32 02/22/19 02/22 07:32 02/22/19 07:32 Recommendations	Opiant Pharmaceuticals analyst commentary » Opiant… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
REGN Regeneron $418.66 -3.9 (-0.92%) 07:32 02/22/19 02/22 07:32 02/22/19 07:32 Downgrade	Regeneron rating change » Regeneron downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb 11 Mar 11 Mar 28 Apr 13 May

INSM Insmed $25.57 -0.42 (-1.62%) 07:31 02/22/19 02/22 07:31 02/22/19 07:31 Earnings	Insmed reports Q4 EPS ($1.19), consensus ($1.06) » Reports Q4 revenue $9.8M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
SHW Sherwin-Williams $438.49 0.56 (0.13%) 07:31 02/22/19 02/22 07:31 02/22/19 07:31 Recommendations	Sherwin-Williams analyst commentary » Sherwin-Williams price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ZGNX Zogenix $47.88 0.35 (0.74%) 07:30 02/22/19 02/22 07:30 02/22/19 07:30 Initiation	Zogenix initiated » Zogenix initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GE General Electric $10.03 -0.07 (-0.69%) , JNJ Johnson & Johnson $135.40 -0.91 (-0.67%) … 07:30 02/22/19 02/22 07:30 02/22/19 07:30 Options	Unusual put flow in option market yesterday » Notable put activity was… GE General Electric $10.03 -0.07 (-0.69%) JNJ Johnson & Johnson $135.40 -0.91 (-0.67%) M Macy's $24.44 -0.58 (-2.32%) CZR Caesars $9.42 -0.21 (-2.18%) KEM Kemet $18.87 -0.56 (-2.88%) COUP Coupa Software $92.20 -1.55 (-1.65%) SM SM Energy $17.01 -2.69 (-13.65%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 26 Feb 27 Feb 03 Mar 06 Mar 11 Mar 12 Mar 12 Mar
ROKU Roku $51.47 -2.16 (-4.03%) 07:29 02/22/19 02/22 07:29 02/22/19 07:29 Recommendations	Roku analyst commentary » Roku price target raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

SM SM Energy $17.01 -2.69 (-13.65%) 07:29 02/22/19 02/22 07:29 02/22/19 07:29 Recommendations	SM Energy analyst commentary » SM Energy price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MRK Merck $79.82 0.38 (0.48%) 07:28 02/22/19 02/22 07:28 02/22/19 07:28 Initiation	Merck initiated » Merck initiated with an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Apr 18 May 17 Jun
SAGE Sage Therapeutics $146.14 -1.32 (-0.90%) 07:28 02/22/19 02/22 07:28 02/22/19 07:28 Initiation	Sage Therapeutics initiated » Sage Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 19 Mar
BMRN BioMarin $88.80 -1.82 (-2.01%) 07:26 02/22/19 02/22 07:26 02/22/19 07:26 Recommendations	BioMarin analyst commentary » BioMarin base business… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
RARX RA Pharmaceuticals $19.59 1 (5.38%) 07:26 02/22/19 02/22 07:26 02/22/19 07:26 Initiation	RA Pharmaceuticals initiated » RA Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

JRVR
Today at 08:00

James River Group - JRVR Conference Calls
W
Today at 08:00

Wayfair - W Conference Calls
BXG
Today at 08:00

Bluegreen Vacations - BXG Conference Calls
KL
Today at 08:00

Kirkland Lake Gold - KL Conference Calls
GLPG
Today at 08:00

Galapagos NV - GLPG Conference Calls
ELGX
Today at 08:00

Endologix Inc. Firm Sponsored Meetings

2 Musick, Irvine, CA
CNK
Today at 08:30

Cinemark - CNK Conference Calls
CLPS
Today at 08:30

CLPS - CLPS Conference Calls
B
Today at 08:30

Barnes Group - B Conference Calls
MNTA
Today at 08:30

Momenta - MNTA Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	RWLK X RWLK ReWalk Robotics Spot Secondary Managers: H.C. Wainwright Priced at: $.23 19M Shares
Thurs	ACAM X ACAM Acamar Partners IPO Managers: Goldman Sachs & Deutsche Bank Priced at: $10.00 30M Shares
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	TRIL X TRIL Trillium Therapeutics Spot Secondary Managers: Cowen $1.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Yeti sees FY19 adjusted EPS 99c-$1.04, consensus 96c

TODAY'S FREE FLY STORIES

Get Full Fly Access